In silico preliminary evaluation of bioactive compounds from five Unani drugs as potential SARS-CoV-2 inhibitors: IN SILICO EVIDENCE OF FIVE UNANI DRUGS AGAINST SARS-COV-2. Indian Journal of Traditional Knowledge (IJTK), [S. l.], v. 23, n. 3, p. 247–261, 2024. DOI: 10.56042/ijtk.v23i3.1412. Disponível em: https://or.niscpr.res.in/index.php/IJTK/article/view/1412. Acesso em: 10 jun. 2026.